TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/5/19 19:52 | 2/1/19 | ARAV | Aravive, Inc. | Health | Drug | Pharmaceutical Preparations | Haas Kevin | TX | O | VP,Finan | S | -1 | 4.14 | 0 | 0 | -2 | 11 | D | |||||||||||||||
12/26/18 19:56 | 12/21/18 | ARAV | Aravive, Inc. | Health | Drug | Pharmaceutical Preparations | Haas Kevin | TX | O | VP,Finan | S | -2 | 3.22 | 0 | -1 | -6 | 11 | D | |||||||||||||||
12/19/18 19:57 | 12/17/18 | ARAV | Aravive, Inc. | Health | Drug | Pharmaceutical Preparations | Haas Kevin | TX | O | VP,Finan | S | -5 | 3.96 | 0 | -1 | -9 | 12 | D | |||||||||||||||
6/19/18 16:52 | 6/15/18 | VSAR | Versartis, Inc. | Health | Drug | Pharmaceutical Preparations | Haas Kevin | CA | O | VP,Finan | S | 0 | 2.30 | 0 | 0 | 0 | 78 | D | |||||||||||||||
2/12/18 17:27 | 2/8/18 | VSAR | Versartis, Inc. | Health | Drug | Pharmaceutical Preparations | Haas Kevin | CA | O | VP,Finan | S | -3 | 1.80 | 0 | -2 | -2 | 78 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |